A detailed history of Northern Trust Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Northern Trust Corp holds 20,284,092 shares of ABBV stock, worth $3.93 Billion. This represents 0.59% of its overall portfolio holdings.

Number of Shares
20,284,092
Previous 20,250,260 0.17%
Holding current value
$3.93 Billion
Previous $3.69 Billion 5.65%
% of portfolio
0.59%
Previous 0.65%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $5.24 Million - $6.12 Million
33,832 Added 0.17%
20,284,092 $3.48 Billion
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $110 Million - $125 Million
-685,853 Reduced 3.28%
20,250,260 $3.69 Billion
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $138 Million - $155 Million
-1,000,166 Reduced 4.56%
20,936,113 $3.24 Billion
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $65.6 Million - $76 Million
491,391 Added 2.29%
21,936,279 $3.27 Billion
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $103 Million - $129 Million
-780,116 Reduced 3.51%
21,444,888 $2.89 Billion
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $38.8 Million - $44.7 Million
268,579 Added 1.22%
22,225,004 $3.54 Billion
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $14.1 Million - $16.9 Million
101,629 Added 0.47%
21,956,425 $3.55 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $42.9 Million - $49.2 Million
-319,948 Reduced 1.44%
21,854,796 $2.93 Billion
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $62.8 Million - $79.9 Million
-456,417 Reduced 2.02%
22,174,744 $3.4 Billion
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $24.6 Million - $30.5 Million
-186,365 Reduced 0.82%
22,631,161 $3.67 Billion
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $194,018 - $245,489
1,806 Added 0.01%
22,817,526 $3.09 Billion
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $17.1 Million - $19.5 Million
161,083 Added 0.71%
22,815,720 $2.46 Billion
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $113 Million - $126 Million
-1,072,864 Reduced 4.52%
22,654,637 $2.55 Billion
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $19 Million - $20.9 Million
-185,978 Reduced 0.78%
23,727,501 $2.57 Billion
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $36.2 Million - $48.9 Million
-449,713 Reduced 1.85%
23,913,479 $2.56 Billion
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $18 Million - $21.2 Million
210,056 Added 0.87%
24,363,192 $2.13 Billion
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $279 Million - $374 Million
3,808,707 Added 18.72%
24,153,136 $2.37 Billion
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $57.8 Million - $87.6 Million
895,939 Added 4.61%
20,344,429 $1.55 Billion
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $13.1 Million - $16.4 Million
-182,144 Reduced 0.93%
19,448,490 $1.72 Billion
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $33.1 Million - $39.8 Million
-525,315 Reduced 2.61%
19,630,634 $1.49 Billion
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $3.69 Million - $4.71 Million
-56,135 Reduced 0.28%
20,155,949 $1.47 Billion
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $63.1 Million - $74.2 Million
-817,581 Reduced 3.89%
20,212,084 $1.63 Billion
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $17.7 Million - $21.8 Million
227,408 Added 1.09%
21,029,665 $1.94 Billion
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $37.8 Million - $42 Million
-425,114 Reduced 2.0%
20,802,257 $1.97 Billion
Q2 2018

Sep 18, 2018

SELL
$89.78 - $106.23 $9.36 Million - $11.1 Million
-104,305 Reduced 0.49%
21,227,371 $1.97 Billion
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $28.8 Million - $34.1 Million
-321,093 Reduced 1.48%
21,331,676 $1.98 Billion
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $41.4 Million - $55.4 Million
-449,836 Reduced 2.04%
21,652,769 $2.05 Billion
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $19.7 Million - $21.6 Million
-220,261 Reduced 0.99%
22,102,605 $2.14 Billion
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $1.56 Billion - $1.99 Billion
22,322,866
22,322,866 $1.98 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.